Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to know if rituximab can improve cognitive and hand functions in secondary progressive multiple sclerosis (SPMS) patients with high disability (EDSS 6.5 or more). Th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cairo University
NCT07225504 · Secondary Progressive Multiple Sclerosis (SPMS)
NCT06677710 · Multiple Sclerosis, Primary Progressive Multiple Sclerosis (PPMS), and more
NCT03387670 · Secondary Progressive Multiple Sclerosis (SPMS)
Kasr Alainy Multiple Sclerosis Unit (KAMSU), Cairo University hospitals.
Giza, Giza Governorate
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions